Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis

Drug Delivery

Volumn 20, Issue 2, 2013, Pages 65-77

  Ramasamy, Thiruganesh ^a,b   Ruttala, Hima Bindu ^c   Shanmugam, Suresh ^d   Umadevi, Subbiah Kandasamy ^d  

^a Yeungnam University   (South Korea)

^b Utah Inha DDS and Advanced Therapeutics   (South Korea)

^c ANDHRA UNIVERSITY   (India)

^d OSMANIA UNIVERSITY   (India)

Author keywords

Aceclofenac; Chronopharmacology; Colonic delivery; Eudragit coating; Pectin microspheres

Indexed keywords

ACECLOFENAC; EMULSIFYING AGENT; EUDRAGIT; MICROSPHERE; PECTIN; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CECUM; CHRONOPHARMACOLOGY; CONTROLLED STUDY; DRUG RELEASE; EMULSION; EVAPORATION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SURFACE PROPERTY; UPPER GASTROINTESTINAL TRACT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CALORIMETRY, DIFFERENTIAL SCANNING; COATED MATERIALS, BIOCOMPATIBLE; DELAYED-ACTION PREPARATIONS; DICLOFENAC; DRUG CARRIERS; DRUG CHRONOTHERAPY; DRUG COMPOUNDING; DRUG STABILITY; GASTRIC JUICE; INTESTINAL SECRETIONS; MALE; MICROSPHERES; PARTICLE SIZE; PECTINS; POLYMETHACRYLIC ACIDS; RATS; RATS, WISTAR; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; TISSUE DISTRIBUTION;

EID: 84875702729     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2012.762434     Document Type: Article

References (68)

1. Ahmed IS. (2005). Effect of simulated gastro intestinal conditions on drug release from pectin/ethylcellulose as film coating for drug delivery to the colon. Drug Dev Ind Pharm 31:465-70.
2. Ahrabi SF, Madsen G, Dyrstad K, et al. (2000). Development of pectin matrix tablets for colonic delivery of model drug ropivacaine. Eur J Pharm Sci 10:43-52.
3. Arora S, Ali J, Ahuja A, et al. (2005). Floating drug delivery system: a review. AAPS Pharm Sci Tech 6:372-90.
4. Ashford M, Fell JT, Attwood D, et al. (1993). An evaluation of pectin as a carrier for drug targeting to the colon. J Control Rel 26:213-20.
5. Basit AW, Podczeck F, Newton JM, et al. (2004). The use of formulation technology to assess regional gastrointestinal drug absorption in humans. Eur J Pharm Sci 21:179-89.
6. Bodmeier R, Krogel I. (1999). Development of multifunctional matrix drug delivery system surrounded by an impermeable cylinder. J Cont Rel 61:43-50.
7. Botti B, Yoan C. (2004). Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery. J Cont Rel 98:337-53.
8. Bozdag-Pehlivan S, Çetin M, Vural I, Unlü N. (2009). Eudragit-coated alginate microspheres for colon specific delivery of indomethacin. Available from: www.aapsj.org/abstracts/AM-2009/AAPS2009-002176. PDF [last accessed May 2011].
9. Castellanos IJ, Carrasquillo KG, de Jesus Lopez J, et al. (2001). Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) micropsheres by the solid-in-oil-in-water technique. J Pharm Pharmacol 53:167-78.
10. Chambin O, Dupuis G, Champion D, et al. (2006). Colon-specific drug delivery: influence of solution reticulation properties upon pectin beads performance. Int J Pharm 321:86-93.
11. Das S, Ng KY, Ho PC. (2011). Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutar-aldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitro and in vivo evaluations. J Drug Target 19:446-57.
12. Demiroz TF, Acarturk F, Takka S, Konus-Boyunaga O. (2004). In-vitro and in-vivo evaluation of mesalazine-guargum matrix tablets for colonic drug delivery. J Drug Target 12:105-12.
13. Edwards C. (1997). Physiology of the colorectal barrier. Adv Drug Del Rev 28:173-90.
14. El-Gibaly I. (2002). Oral delayed-release system based on zn-pectinate gel (ZPG) microparticles as an alternative carrier to calcium pectinate beads for colonic drug delivery. Int J Pharm 232:199-211.
15. Food and Drug Administration (1997). Guidance for industry: dissolution testing of immediate release solid oral dosage forms. fishers lane. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research.
16. Fu X, Ping Q, Gao Y. (2005). Effects of formulation factors on encapsulation efficiency and release behavior in vitro of huperzine A-PLGA microspheres. J Microencapsul 22:705-14.
17. Gabor F, Ertl B, Wirth M, Mallinger R. (1999). Ketoprofen-poly(d, l-lactic co glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics. J Microencapsul 16:1-12.
18. Gaikwad M, Belgamwar V, Tekade A, et al. (2010). Formulation and evaluation of floating, pulsatile, multiparticulates using pH-dependent swellable polymers. Pharm Dev Tech 15:209-16.
19. Glenn B, Gray J, Di VM, et al. (1965). Chemical changes in adjuvant induced polyarthritis of rats. Ann J Ven Res 26:1195-203.
20. Godefroy F, Besson JM, Butler SH, et al. (1992). A limited arthritic model for chronic pain studies in the rat. Pain 48:73-81.
21. Hao Z, Xuetao J, Lingshan K, Shen G. (2007). Design and gamma-scintigraphic evaluation of a floating and pulsatile drug delivery system based on an impermeable cylinder. Chem Pharm Bull 55:580-5.
22. He W, Du Q, Cao DY, et al. (2007). Pectin/ethylcellulose as film-coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets. PDAJ Pharm Sci Technol 61:121-30.
23. Hungl D, Siebertl G, Changl P, et al. (2006). Hepatic pharmacokinetics of propranolol in rats with adjuvant-induced systemic inflammation. Am J Physiol Gastrointest Liver Physiol 290:G343-51.
24. Jain A, Gupta Y, Jain SK. (2008). Potential of calcium pectinate beads for target specific drug release to colon. J Drug Target 15: 285-94.
25. Jain SK, Rai G, Saraf DK, Agrawal GP. (2008). The preparation and evaluation of albendazole microspheres for colonic delivery. Pharm Tech 12:45-51.
26. Kawamura T, Ohisa Y, Abe Y, et al. (1992). Plasma lipid peroxides in the operation of oesophageal cancer. Rinsho-Ayori 40:881-4.
27. Khatun M, Islam A, Akter P, et al. (2005). Controlled release of naproxen sodium from Eudragit RS 100 transdermal film. J Pharm Sci 3:1-2.
28. Krishnaiah YSR, Satyanarayana V, Dineshkumar B, Karthikeyan RS. (2002). In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil. Eur J Pharm Sci 16:185-92.
29. Krishnaiah YSR, Satyanarayana V, Kumar BD. (2003). In vivo pharmacokinetics in human volunteers: oral administered guargum-based colon-targeted 5-fluorouracil tablets. Eur J Pharm Sci 19:355-62.
30. Krishnaiah YSR, Satyanarayana S, Rama Prasad YV, Narasimha Rao S. (1998). Evaluation of guargum as a compression coat for drug targeting to colon. Int J Pharm 171:137-46.
31. Lemoine D, Wauters F, Bouchend S, Preat V. (1998). Preparation and characterization of alginate microspheres containing model antigen. Int J Pharm 176:9-19.
32. Liu L, Fishman ML, Kost J, Hicks KB. (2003). Pectin-based systems for colon-specific drug delivery via oral route. Biomaterials 24: 3333-43.
33. Lorenzo-Lamosa ML, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. (1998). Design of microencapsulated chitosan microspheres for colonic drug delivery. J Cont Rel 52:109-18.
34. Macleod GS, Fell JT, Collett JH, et al. (1999). Selective drug delivery to the colon using pectin: chitosan: hydroxyl propyl methyl cellulose film coated, tablets. Int J Pharm 187:251-7.
35. Maestrelli F, Cirri M, Corti G, et al. (2008). Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery. Eur J Pharm Biopharm 69:508-18.
36. Marianne H, Ingunn T, Sverre AS. (2003). The formation and permeability of drugs across free pectin and chitosan films prepared by a spraying method. Eur J Pharm Biopharm 56:175-82.
37. McConnell EL, Tutas J, Mohamed MAM, et al. (2007). Colonic drug delivery using amylase films: the role of aqueous ethyl cellulose dispersions in controlling drug release. Cellulose 14:25-34.
38. Mehrgan H, Mortazavi SA. (2005). The release behavior and kinetic evaluation of diltiazem HCl from various hydrophilic and plastic based matrices. Iran J Pharm Res 3:137-46.
39. Milojevic S, Newton JM, Cummings JH, et al. (1996). Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using 5-aminosalicylic acid pellets. J Cont Rel 38:75-84.
40. Momin M, Pundarikakshudu K. (2004). In vitro studies on guar gum based formulation for the colon targeted delivery of Sennosides. J Pharm Pharmaceut Sci 7:325-31.
41. Niino-Nanke NY, Akama H, Hara M, et al. (1998). Alkaline phasphatase (ALP) activity in rheumatoid arthritis-its clinical significance and synthesis of ALP in RA synovium. Ryumachi 38:581-8.
42. Nurjaya S, Wong TW. (2005). Effect of microwave on drug release properties of matrices of pectin. Carb Polym 62:245-57.
43. Paharia A, Yadav AK, Rai G, et al. (2007). Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. AAPS Pharm Sci Tech 8:1-12.
44. Patel VM, Prajapati BG, Patel MM. (2007). Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride. AAPS Pharm Sci Tech 8:E147-54.
45. Pillay V, Fassihi R. (1999). In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract: II. Physico-chemical characterization of calcium-alginate, calcium-pectinate and calcium-alginate-pectinate pellets. J Cont Rel 59:243-56.
46. Queen MC, Silvia C, Lai A, Amiji PMC. (2000). Surface and blood interaction properties of polyethylene oxide modified pectin micro-spheres. STP Pharm Sci 10:95-100.
47. Rainsford KD. (1982). Adjuvant polyarthritis in rats: is this a satisfactory model for screening anti-arthritic drugs? Agents Actions 12:452-8.
48. Rang AP, Dale MM, and Ritter JM. (2001). Pharmacology. 4th edn. London: Churchill Livingstone, 229-36.
49. Richman DD, Fischl MA, Grieco MH. (1987). The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS related complex. N Engl J Med 317:192-7.
50. Ritger PL, Peppas NA. (1987). A simple equation for description of solute release. II Fickian and anomalous release from swellable devices. J Cont Rel l5:37-42.
51. Rodriguez M, Vila-Jato JL, Torres D. (1998). Design of new multi-particulate system for potential site specific and controlled drug delivery to the colonic region. J Cont Rel 55:67-77.
52. Rubinstein A, Radai R. (1995). In vitro and in vivo analysis of colon specificity of calcium pectinate formulations. Eur J Biopharm 41:291-5.
53. Semde R, Amighi K, Devleeschouwer MJ, Moes AJ. (2000). Studies of pectin HM/Eudragit RL/Eudragit NE film-coating formulations intended for colonic drug delivery. Int J Pharm 197:181-92.
54. Shimono N, Takatori T, Ueda M, et al. (2002). Chitosan dispersed system for colon-specific drug delivery. Int J Pharm 245:45-54.
55. Sinha VR, Mittal BR, Bhutani KK, Kumria R. (2004a). Colonic drug delivery of 5-fluorouracil: an in vitro evaluation. Int J Pharm 269:101-8.
56. Sinha VR, Singla AK, Wadhawan S, et al. (2004b). Pectin microspheres as a potential carrier for drugs. Int J Pharm 274:1-33.
57. Tugcu-Demiroz F, Acarturk F, Takka S, Konus-Boyunaga O. (2008). In-vitro and in-vivo evaluation of mesalazine-guargum matrix tablets for colonic drug delivery. J Drug Target 12:105-12.
58. United States Pharmacopoeia (2008). 19th edn. Rockville, Maryland, USA. Available from: http://www.usp.org [last accessed April 2011].
59. Vaidya A, Jain A, Khare P, et al. (2009). Metronidazole loaded pectin microspheres for colon targeting. J Pharm Sci 98:4229-36.
60. Wakerly Z, Fell JT, Attwood D, Parkins D. (1996a). In vitro evaluation of pectin-based colonic drug delivery systems. Int J Pharm 129:73-7.
61. Wakerly Z, Fell JT, Attwood D, Parkins D. (1996b). Pectin/ethylcellulose film coating formulations for colonic drug delivery. Pharm Res 13:1210-12.
62. Wei J, Yuan WG, Qiang NC, Gen PX. (2003). Anti-inflammatory effects of an herbal medicine on carrageenan and adjuvant induced paw edema in rats. J Ethno Pharmacol 89:139-41.
63. Winter CA, Risley EA, Nuss GW. (1962). Carrageenin-induced edema in hind paw of the rat as an assay for anti inflammatory drugs. Proc Soc Exp Biol Med 111:544-7.
64. Xi MM, Zhang SQ, Wang XY, et al. (2005). Study on the characteristics of pectin-ketoprofen for colon targeting in rats. Int J Pharm 298:91-7.
65. Xu C, Zhang JS, Mo Y, Tan RX. (2005). Calcium pectinate capsules for colon-specific drug delivery. Drug Dev Ind Pharm 31:127-34.
66. Yagi K. (1987). Lipid peroxides and human diseases. Chem Phys Lipids 45:337-51.
67. Yamaguchy S. (1991). The role of SOD an antioxidant. J Natl Cancer Inst 28:221-32.
68. Yang MS, Cui FD, You BG, et al. (2003). Preparation of sustained-release nitrendipine microspheres with eudragit RS and aerosil using quasi-emulsion solvent diffusion method. Int J Pharm 259:103-13.